
|Articles|March 1, 2018
- Pharmaceutical Executive-03-01-2018
- Volume 38
- Issue 3
Pharmaceutical Executive, March 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharma: Meet Your New Neighborsover 8 years ago
Risk Sharing, Italian Styleover 8 years ago
The Quest to Measure Upover 8 years ago
Full Disclosure Demanded for Pharma Industryover 8 years ago
Setting the Standard: William Soliman, ACMAover 8 years ago
The Law of Unintended Consequencesover 8 years ago
Pricing Turning Point: The Case for Innovating Pharma’s Modelover 8 years ago
Showdown Nears on Europe Research Incentivesover 8 years ago
The Personalized Genetic Profile: It’s Time to Alignover 8 years ago
Country Report: IndiaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
2
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
3
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
4
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
5




